SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 12:29 pm Sale |
2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
SUVRETTA CAPITAL MANAGEMENT LLC | 9,534,837 9.990% |
-57,375 (-0.60%) |
Filing |
| 2023-10-30 5:03 pm Purchase |
2023-10-20 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
SUVRETTA CAPITAL MANAGEMENT LLC | 9,592,212 9.990% |
9,592,212 (New Position) |
Filing |